Puma Biotechnology Inc (PBYI)
2.985
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 14, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Debt to Equity Ratio: 1.836 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.836 |
| March 31, 2024 | 1.962 |
| December 31, 2023 | 1.865 |
| September 30, 2023 | 2.563 |
| June 30, 2023 | 3.255 |
| March 31, 2023 | 3.816 |
| December 31, 2022 | 4.550 |
| September 30, 2022 | 4.423 |
| June 30, 2022 | 4.949 |
| March 31, 2022 | 13.63 |
| December 31, 2021 | -39.69 |
| September 30, 2021 | -8.863 |
| June 30, 2021 | 3.398 |
| March 31, 2021 | 6.035 |
| Date | Value |
|---|---|
| December 31, 2020 | -16.52 |
| September 30, 2020 | -215.07 |
| June 30, 2020 | 4.126 |
| March 31, 2020 | 10.21 |
| December 31, 2019 | 5.438 |
| September 30, 2019 | 5.482 |
| June 30, 2019 | 4.292 |
| March 31, 2019 | 3.516 |
| December 31, 2018 | 4.427 |
| September 30, 2018 | 2.637 |
| June 30, 2018 | 3.140 |
| March 31, 2018 | 0.8451 |
| December 31, 2017 | 0.9095 |
| September 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-215.07
Minimum
Sep 2020
13.63
Maximum
Mar 2022
-10.95
Average
3.398
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7219 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 205.00M |
| Total Liabilities (Quarterly) | 156.49M |
| Shareholders Equity (Quarterly) | 48.51M |
| Current Ratio | 1.320 |
| Net Debt Paydown Yield | 1.21% |